e8vk
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 6, 2004

ATRIX LABORATORIES, INC.

(Exact Name of Registrant as Specified in Charter)
         
Delaware   0-18231   84-1043826
  		 
  		 
 
(State or Other
Jurisdiction of
Incorporation) 		  (Commission File Number)   (IRS Employer
Identification No.)
         
2579 Midpoint Drive, Fort Collins, Colorado
   80525
(Address of Principal Executive Offices)
   (Zip Code)

Registrant’s telephone number, including area code (970) 482-5868

 

 

Item 12. Results of Operations and Financial Condition.

     On May 6, 2004, Atrix Laboratories, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2004. A copy of the press release is furnished as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit are furnished to, but not filed with, the Securities and Exchange Commission.

2

 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
  ATRIX LABORATORIES, INC.
 		  
  By:   /s/ Gregory A. Gould    
    Gregory A. Gould   
Date: May 6, 2004    Chief Financial Officer, Secretary and Treasurer   
 

3

 

EXHIBIT INDEX

         
Exhibit
   Description
99.1
   Press Release dated May 6, 2004